Understanding Chronic Myelogenous Leukemia
CML is a cancer of the blood. In people with CML, there is a disruption in the process that governs the normal life cycle of white blood cells. As a result, too many white blood cells develop.
Welcome to Leukemia Innovations, a Web site dedicated to advancing the care and treatment of the approximately 16,000 people living with chronic myeloid leukemia (CML) in the United States. LeukemiaInnovations.com is committed to providing the best scientific-based information by drawing on the expertise of leading leukemia experts from around the world.
CML became one of the most well-understood cancers when a gene mutation called the Philadelphia chromosome was discovered more than 40 years ago. Since then treatments such as high dose chemotherapy with stem cell transplantation and targeted therapies have improved long-term outcome and survival. But even given these remarkable advances, more CML treatment research is needed. LeukemiaInnovations.com brings you updates on the treatment issues that people living with CML face, and on treatments on the horizon.
